Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00518921
Status:
WITHDRAWN
Last Update Posted:
2011-01-13
First Post:
2007-08-20
Brief Title:
Capadenoson in Angina Pectoris
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
Phase IIa Efficacy and Safety Trial of Capadenoson in Patients With Chronic Stable Angina
Status:
WITHDRAWN
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multi-center and multi-nationalrandomized double blind placebo-controlled 28-day treatment study with BAY 68-4986 taken orally or a matching placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EudraCT 2007-000425-22 | None | None | None |